AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cardiff Oncology's management team will participate in a fireside chat and 1x1 investor meetings at the Piper Sandler 37th Annual Healthcare Conference from December 2-4, 2025. CEO Mark Erlander, PhD, will discuss the company's clinical-stage biotechnology development of novel therapies for various cancers through PLK1 inhibition. Interested parties can register for and access the live webcast on the Cardiff Oncology website.
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet